<DOC>
	<DOCNO>NCT00373503</DOCNO>
	<brief_summary>The purpose study investigate interaction marijuana two potential treatment medication : lofexidine oral THC , direct goal use information improve marijuana treatment outcome .</brief_summary>
	<brief_title>Effect Lofexidine Oral THC Marijuana Withdrawal Relapse</brief_title>
	<detailed_description>Only small percentage dependent-marijuana smoker seek treatment marijuana use able achieve sustain abstinence . The objective study investigate interaction marijuana two potential treatment medication : lofexidine oral THC , direct goal use information improve marijuana treatment outcome . In mouse , α2-receptor agonist , clonidine , reverse symptom cannabinoid withdrawal ( Lichtman et al. , 2001 ) . The purpose study determine lofexidine , α2-receptor agonist favorable side-effect profile clonidine , decrease symptom marijuana withdrawal thus decrease marijuana relapse , compare placebo . Oral THC FDA-approved appetite enhancement . Lofexidine , currently FDA-approved , use Europe treat symptom heroin withdrawal , treat hypertension . For purpose model , relapse define return marijuana use period abstinence . We show oral THC reduces symptoms marijuana withdrawal dose produce minimal intoxication ( Haney et al. , 2004 ) . Thus , effect oral THC alone combination lofexidine determine . The study utilize inpatient/outpatient , counter-balanced design , participant maintain four medication condition 8 day : placebo , lofexidine , oral THC , oral THC combine lofexidine . During inpatient study phase , participant opportunity self-administer placebo active marijuana 6 time per day . Outpatient phase medication clearance medication administer . This study provide important information effect potential treatment medication marijuana withdrawal symptom , subsequent marijuana self-administration .</detailed_description>
	<mesh_term>Marijuana Abuse</mesh_term>
	<mesh_term>Dronabinol</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<mesh_term>Lofexidine</mesh_term>
	<criteria>Current marijuana use : average 3 marijuana cigarette least 4 time per week past 4 week Able perform study procedure 2145 year age Women practice effective form birth control ( condom , diaphragm , birth control pill , IUD ) Current , repeat illicit drug use ( marijuana ) Presence significant medical illness ( e.g. , diabetes , cardiovascular disease , hypertension , clinically significant laboratory abnormality ) Bradycardia ( 55 beats/minute ) , hypotension ( &lt; 90 mmHg ) include orthostatic hypotension ( &gt; 20 mmHg decrease SP , &gt; 10 mmHg decrease DP upon stand History heart disease Request drug treatment Current parole probation Pregnancy current lactation Recent history significant violent behavior Major current Axis I psychopathology ( e.g. , major depressive disorder , bipolar disorder , suicide risk , schizophrenia ) Current use prescription overthecounter medication</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Lofexidine</keyword>
	<keyword>Oral THC</keyword>
	<keyword>Cannabinoids</keyword>
</DOC>